Insulet Reports First Quarter 2020 Revenue Increase of 24% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Insulet (PODD) Misses Q1 EPS by 3c, Revenues Beat
May 7, 2020 5:50 PM EDTInsulet (NASDAQ: PODD) reported Q1 EPS of ($0.03), $0.03 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $198 million versus the consensus estimate of $189.58 million.
First Quarter Financial Highlights:
First quarter 2020 revenue of $198.0 million, up 24.1%, or 25.3% in constant currency1, compared to $159.6 million in the prior year, exceeds guidance of 17% to 20% revenue growth, or 18% to 21% on a constant currency basisTotal Omnipod revenue of $189.7 million, an increase of 32.7%, or 34.0% in constant currencyU.S. Omnipod revenue of $116.6 million, an increase of 35.4%International Omnipod revenue of $73.1 million, an increase of 28.5%, or... More


